|
2025
|
P/S
|
Computer software for the display of digital media; Artificial intelligence software for analysis... |
|
|
P/S
|
Software; Machine learning software for finance; Computer search engine software; Software for se... |
|
|
P/S
|
Software; Computer software platforms; Machine learning software; Computer search engine software... |
|
|
Invention
|
Antitumor parasporin-2 derived toxins. The invention relates to a recombinant parasporin 2 protei... |
|
|
Invention
|
Oncolytic adenovirus with controlled replication. The present invention relates to oncolytic viru... |
|
|
Invention
|
Compounds for treating diseases. The invention relates to an oligomer comprising at least three p... |
|
2024
|
Invention
|
Oncolytic adenoviruses for treating cancer.
The invention is related to an oncolytic adenovirus ... |
|
2023
|
Invention
|
Pd-ecgf as biomarker of cancer. The present invention corresponds to the field of cancer and is r... |
|
|
Invention
|
Ursodeoxycholic acid derivatives for the treatment of polycystic diseases.
Compounds derived fro... |
|
|
Invention
|
Adenovirus comprising an albumin-binding moiety.
The invention relates to a recombinant adenovir... |
|
2022
|
Invention
|
Asenapine for use in cancer. It relates to a compound of formula (I), particularly asenapine, or ... |
|
2021
|
Invention
|
Diagnosis of allograft antibody-mediated rejection. SIGLEC17P AP4S1, ZMYM6, USP21, DMAP1, SUPT5H,... |
|
|
Invention
|
Methods for predicting the risk of local invasion and/or metastasis induced by an antiangiogenic ... |
|
|
Invention
|
Dna damage repair deficit in cancer cells. Presented are methods of assessing a deficit in DNA da... |
|
|
Invention
|
Mitochondrial markers of neurodegenerative diseases. The present invention relates to an in vitro... |
|
|
Invention
|
In vitro methods for the prognosis of amyotrophic lateral sclerosis. in vitro in vitro method and... |
|
|
Invention
|
Method and kit for the early detection of sepsis.
The invention relates to in vitro methods for ... |
|
|
Invention
|
Method and kit for the early detection of sepsis. The invention relates to in vitro methods for d... |
|
2020
|
Invention
|
Compounds for immunomodulation.
The invention relates to compounds based on a recombinant form o... |
|
|
Invention
|
Compounds for immunomodulation. The invention relates to compounds based on a recombinant form of... |
|
|
Invention
|
Ergothioneine, s-methyl-ergothioneine, and uses thereof.
The present invention provides S-methyl... |
|
|
Invention
|
Ergothioneine, s-methyl-ergothioneine, and uses thereof. The present invention provides S-methyl-... |
|
|
Invention
|
Succinate as a biomarker for selecting a bariatric surgical procedure and for predicting type 2 d... |
|
|
Invention
|
Eph2a aptamer and uses thereof.
The present invention belongs to the field of genetic therapy. I... |
|
|
Invention
|
Eph2a aptamer and uses thereof. The present invention belongs to the field of genetic therapy. In... |
|
|
Invention
|
Composition for improving the culture and implantation of mammalian embryos, preparation method a... |
|
|
Invention
|
Composition for improving the culture and implantation of mammalian embryos,preparation method an... |
|
|
Invention
|
Fusion protein with immunosuppressive activity.
The present invention provides a compound compri... |
|
|
Invention
|
Fusion protein with immunosuppressive activity. The present invention provides a compound compris... |
|
2019
|
Invention
|
In vitro method for the prediction of response to chemotherapy in triple negative breast cancer p... |
|
|
P/S
|
Downloadable software for the provision of telemedicine and for tracking, monitoring, reporting, ... |
|
|
P/S
|
Software platform for computers, social networks and mobile
telephones, downloadable software. I... |
|
2018
|
Invention
|
Ursodeoxycholic acid derivatives as hdac inhibitors for the treatment of polycystic diseases. The... |
|
|
P/S
|
Computer software platforms for use in providing multiple user access to a global computer inform... |
|
|
Invention
|
C4bp-based compounds for treating immunological diseases. 2. Pharmaceutical compositions comprisi... |
|
|
Invention
|
C4bp-based compounds for treating immunological diseases. The invention relates to compounds for ... |
|
2016
|
Invention
|
Rectal topical lipogel comprising an anesthetic agent and a non-steroidal anti-inflammatory agent... |
|
|
Invention
|
Methods and compositions for the diagnosis and for the treatment of adrenoleukodystrophy.
The ... |
|
|
Invention
|
Methods and compositions for the diagnosis and for the treatment of adrenoleukodystrophy. The pre... |
|
2015
|
Invention
|
Method for the prognosis of hepatocellular carcinoma. The invention relates to a method for the p... |
|
|
Invention
|
Adenovirus comprising an albumin-binding moiety. The invention relates to a recombinant adenoviru... |
|
|
Invention
|
Mitochondrial markers of neurodegenerative diseases. Disclosed is an in vitro method to diagnose ... |
|
|
Invention
|
Mitochondrial markers of neurodegenerative diseases. The invention relates to an in vitro method ... |
|
|
Invention
|
Systems for providing oxygen to a patient. System for providing oxygen to a patient, comprising a... |
|
2014
|
Invention
|
Multi-target drug compounds for the treatment of neurodegenerative disorders. The compounds of fo... |
|
2013
|
Invention
|
Systems and methods for pain treatment using neuromodulation. Systems and methods for neuropathic... |
|
|
Invention
|
Immunoadsorbent compositions comprising hyaluronic acid oligosaccharides. The present invention r... |
|
|
Invention
|
Methods and reagents for prevention and/or treatment of transplant rejection. The present inventi... |
|
2012
|
Invention
|
Genetically modified mesenchymal stem cells expressing sst2 for the treatment of airway immune in... |
|
|
Invention
|
Strategies for prevention and/or treatment of diseases based on cd40 silencing.
The present inve... |
|
|
Invention
|
Compositions and methods for immunomodulation. The invention relates to methods and reagents for ... |
|
|
Invention
|
Method for the identification of the origin of a cancer of unknown primary origin by methylation ... |
